Drug Patents owned by Btcp Pharma

1. Drug name - LAZANDA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9814705 BTCP PHARMA Intranasal spray device containing pharmaceutical composition Jan, 2024

(1 year, 3 months from now)

US9078814 BTCP PHARMA Intranasal spray device containing pharmaceutical composition Jan, 2024

(1 year, 3 months from now)

US8889176 BTCP PHARMA Method of managing or treating pain Jan, 2024

(1 year, 3 months from now)

US8216604 BTCP PHARMA Method of managing or treating pain Oct, 2024

(2 years from now)

US9731869 BTCP PHARMA Container Jan, 2032

(9 years from now)

Drugs and Companies using FENTANYL CITRATE ingredient

Treatment: Management of breakthrough pain in patients with cancer

Dosage: SPRAY, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
EQ 0.1MG BASE SPRAY, METERED;NASAL Prescription
EQ 0.3MG BASE SPRAY, METERED;NASAL Discontinued
EQ 0.4MG BASE SPRAY, METERED;NASAL Prescription

2. Drug name - SUBSYS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10610523 BTCP PHARMA Sublingual fentanyl spray Jan, 2027

(4 years from now)

US8835459 BTCP PHARMA Sublingual fentanyl spray Jan, 2027

(4 years from now)

US10016403 BTCP PHARMA Sublingual fentanyl spray Jan, 2027

(4 years from now)

US9241935 BTCP PHARMA Sublingual fentanyl spray Jan, 2027

(4 years from now)

US8835460 BTCP PHARMA Sublingual fentanyl spray and methods of treating pain Jan, 2027

(4 years from now)

US9642797 BTCP PHARMA Sublingual fentanyl spray and methods of use to treat pain Jan, 2027

(4 years from now)

US9289387 BTCP PHARMA Method of treating pain by administering sublingual fentanyl spray Jan, 2027

(4 years from now)

US9642844 BTCP PHARMA Sublingual fentanyl spray Jan, 2027

(4 years from now)

US8486973 BTCP PHARMA Sublingual fentanyl spray Apr, 2030

(7 years from now)

US8486972 BTCP PHARMA Sublingual fentanyl spray Apr, 2030

(7 years from now)

Drugs and Companies using FENTANYL ingredient

Treatment: Treatment of pain

Dosage: SPRAY;SUBLINGUAL

More Information on Dosage
Strength Dosage Availability
0.1MG SPRAY;SUBLINGUAL Prescription
0.2MG SPRAY;SUBLINGUAL Prescription
0.4MG SPRAY;SUBLINGUAL Prescription
0.6MG SPRAY;SUBLINGUAL Prescription
0.8MG SPRAY;SUBLINGUAL Prescription
1.2MG SPRAY;SUBLINGUAL Prescription
1.6MG SPRAY;SUBLINGUAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.